Abstract

Toll-like Receptor 3 (TLR3) detects double-stranded (ds) RNAs to activate innate immune responses. While poly(I:C) is an excellent agonist for TLR3 in several cell lines and in human peripheral blood mononuclear cells, viral dsRNAs tend to be poor agonists, leading to the hypothesis that additional factor(s) are likely required to allow TLR3 to respond to viral dsRNAs. TLR3 signaling was examined in a lung epithelial cell line by quantifying cytokine production and in human embryonic kidney cells by quantifying luciferase reporter levels. Recombinant 1b hepatitis C virus polymerase was found to enhance TLR3 signaling in the lung epithelial BEAS-2B cells when added to the media along with either poly(I:C) or viral dsRNAs. The polymerase from the genotype 2a JFH-1 HCV was a poor enhancer of TLR3 signaling until it was mutated to favor a conformation that could bind better to a partially duplexed RNA. The 1b polymerase also co-localizes with TLR3 in endosomes. RNA-binding capsid proteins (CPs) from two positive-strand RNA viruses and the hepadenavirus hepatitis B virus (HBV) were also potent enhancers of TLR3 signaling by poly(I:C) or viral dsRNAs. A truncated version of the HBV CP that lacked an arginine-rich RNA-binding domain was unable to enhance TLR3 signaling. These results demonstrate that several viral RNA-binding proteins can enhance the dsRNA-dependent innate immune response initiated by TLR3.

Highlights

  • Viral nucleic acids are agonists for innate receptors that can activate anti-viral responses [1,2,3,4]

  • Two of the viral capsid proteins we examined are from members of the alphavirus-like superfamily with positive-stranded RNA genomes: Ross River virus (RRV) and Brome mosaic virus (BMV) [31,32]

  • Viral dsRNAs are poor agonists for Toll-like Receptor 3 (TLR3) We have anecdotally observed that cultured cell lines that express TLR3 respond poorly to viral dsRNAs when compared to the response to poly(I:C)

Read more

Summary

Introduction

Viral nucleic acids are agonists for innate receptors that can activate anti-viral responses [1,2,3,4]. The receptors include the RIG-I-like receptors that are localized to the cell cytoplasm and several membrane-associated Toll-like receptors [5,6]. Mutations in these receptors have been correlated with pathologies in viral infections in humans [7,8,9,10]. Ligand binding induces the TLR3 dimer to orient the two TIR domains to recruit adaptor proteins and activate signal transduction [6,14]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.